美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物科技指數ETF-iShares Nasdaq

190.52

+2.191.16%

盤後：190.30-0.2200-0.12%17:14 EDT

成交量：104.44萬

成交額：1.98億

市值：94.31億

市盈率：30.18

高：190.93

開：190.03

低：188.82

收：188.33

52周最高：199.05

52周最低：130.25

股本：4,950.00萬

流通股本：4,950.00萬

量比：0.87

換手率：2.11%

股息：0.41

股息率：0.22%

每股收益(TTM):6.31

每股收益(LYR):-1.4940

淨資產收益率：24.54%

總資產收益率：0.10%

市淨率：1.16

市盈率(LYR):-127.53

資料載入中...

總覽公司新聞公告

福泰製藥百億收購案引爆市場，Crinetics盤後股價翻倍飆升，終盤收漲101%至84.80美元

生物製藥公司Crinetics盤後升逾100%福泰製藥將以85美元/股收購公司。

Vertex將以100億美元收購Crinetics

Crinetics與福泰製藥交易預計2029年提升後者非GAAP運營收入

Crinetics Pharmaceuticals：融資獲美國銀行與摩根士丹利的45億美元全額承諾過橋貸款支持

福泰製藥就囊性纖維化療法Alyftrek與泛加拿大藥品聯盟簽署意向書

再生元製藥公司預計2026年第二季度GAAP及非GAAP每股攤薄收益將減少1美元——SEC文件披露

景澤生物三次遞表港交所，核心產品均為生物類似藥，投後估值約32.1億元

美國研究綜述-東西銀行、第一公民銀行控股公司、UMB

禮來與再生元製藥公司入選FDA首批加速新生產設施審查計劃

《股市簡訊》香港華夏恒生生科ETF漲5.7%創近兩個月新高，管理人料低估修復

ETF日報｜2倍沽空閃迪ETF 漲逾28%；三倍沽空半導體ETF 漲近17%；成長承壓、貴金屬走強

ETF日報｜2倍做多Firefly Aerospace ETF升逾36%；2倍做多Arm ETF升逾32%；成長科技與貴金屬雙強

ETF日報｜2倍做多Hims & Hers ETF升逾81%；三倍做多半導體ETF升逾11%；成長風格領跑

老虎资讯综合

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IBB/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":190.52,"timestamp":1785268800000,"preClose":188.33,"halted":0,"volume":1044432,"hourTrading":{"tag":"盘后","latestPrice":190.3,"preClose":190.52,"latestTime":"17:14 EDT","volume":711,"amount":135439.76934,"timestamp":1785273294124,"change":-0.22,"changeRate":-0.001155,"amplitude":0.011279},"delay":0,"changeRate":0.01162852439866191,"floatShares":49500000,"shares":49500000,"eps":6.311863,"marketStatus":"盤後交易","change":2.19,"latestTime":"07-28 17:26:23 EDT","open":190.03,"high":190.93,"low":188.82312,"amount":198253664.4672,"amplitude":0.011187,"askPrice":191.34,"askSize":1600,"bidPrice":189.09,"bidSize":1900,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1785283200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":188.33,"sharesOutstanding":49450000,"nav":188.173992,"aum":9352247402.4,"dividendRate":0.002172,"bidAskSpread":0.00038,"preHourTrading":{"tag":"盘前","latestPrice":189.6,"preClose":188.33,"latestTime":"09:27 EDT","volume":898,"amount":170329.52394,"timestamp":1785245220404,"change":1.27,"changeRate":0.006743,"amplitude":0.016036},"postHourTrading":{"tag":"盘后","latestPrice":190.3,"preClose":190.52,"latestTime":"17:14 EDT","volume":711,"amount":135439.76934,"timestamp":1785273294124,"change":-0.22,"changeRate":-0.001155,"amplitude":0.011279},"volumeRatio":0.872805,"impliedVol":0.226,"impliedVolPercentile":0.4661},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":49500000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.872805,"shares":49500000,"dividePrice":0.4139,"high":190.93,"amplitude":0.011187,"preClose":188.33,"low":188.82312,"week52Low":130.25,"pbRate":"1.16","psRate":"226.90","week52High":199.05,"institutionHeld":0,"latestPrice":190.52,"committee":0.085714,"eps":6.311863,"divideRate":0.002172,"volume":1044432,"delay":0,"ttmEps":6.311863,"open":190.03,"prevYearClose":168.77,"prevWeekClose":188.14,"prevMonthClose":190.19,"prevQuarterClose":190.19,"fiveDayClose":189.31,"twentyDayClose":189.79,"sixtyDayClose":168.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1130028229","title":"福泰製藥百億收購案引爆市場，Crinetics盤後股價翻倍飆升，終盤收漲101%至84.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130028229","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130028229?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:17","pubTimestamp":1783369041,"startTime":"0","endTime":"0","summary":"在福泰制药宣布一项价值高达100亿美元的收购协议后，Crinetics Pharmaceuticals Inc.的股价在盘后交易时段应声暴涨，涨幅超过一倍。截至最新数据，该公司股价飙升101%，报收于每股84.80美元。福泰制药的巨额收购计划，不仅彰显了其在相关治疗领域的战略雄心，也直接将收购标的Crinetics推向了资本市场的聚光灯下。对于Crinetics而言，这笔交易意味着其研发价值获得了市场顶尖参与者的高度认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU2417539215.USD","LU1778281490.HKD","BK4533","LU0417517546.SGD","LU0823416689.USD","LU1035775433.USD","LU2362541513.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU2362540622.SGD","PBE","IBB","LU2236285917.USD","LU1093756325.SGD","IE00B894F039.SGD","IE0002141913.USD","LU1430594728.SGD","LU1069344957.HKD","IE0002270589.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU2462157665.USD","LU1585245621.USD","LU2456880835.USD","BIB","VRTX","IBBQ","LU1674673428.USD","LU0256863811.USD","BK4585","BK4567","SGXZ57979304.SGD","LU0079474960.USD","IE00B19Z3581.USD","BBH","BK4007","IDNA","LU0320765992.SGD","LU1674673691.USD","SG9999013999.USD","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","BK4139","LU2324357040.USD","LU1093756168.USD","IE00BJT1NW94.SGD","LU0061475181.USD","IE00B19Z9P08.USD","LU0109394709.USD","BK4532","LU0234570918.USD","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","LU2237438978.USD","SG9999001176.USD","CRNX","SG9999001176.SGD","LU2362541273.HKD","BK4588","LU0058720904.USD","LU0889565916.HKD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679149","title":"生物製藥公司Crinetics盤後升逾100%福泰製藥將以85美元/股收購公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679149?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:09","pubTimestamp":1783368555,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","MRNY","LU1585245621.USD","LU1778281490.HKD","BK4585","BBH","UUP","BK4588","LU1674673428.USD","BK4533","IE00B19Z9P08.USD","SGXZ57979304.SGD","LU0061475181.USD","BIB","BK4567","IBBQ","IDNA","IE0002141913.USD","LU1093756168.USD","LU2362541273.HKD","LU0320765992.SGD","LU1093756325.SGD","LU2417539215.USD","LU2236285917.USD","LU1035775433.USD","LU2456880835.USD","IE00BFTCPJ56.SGD","SG9999013999.USD","IE00BJJMRZ35.SGD","IE00B19Z9Z06.USD","UDN","BBP","LU0823416689.USD","MRNX","LU0289739699.SGD","LU2237438978.USD","LU1674673691.USD","SG9999001176.USD","IE00B2B36J28.USD","IBB","LU2362541513.USD","LU0079474960.USD","IE00B19Z3581.USD","IE00BJT1NW94.SGD","LU2324357040.USD","VRTX","LU2362540622.SGD","BK4532","PBE","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679469","title":"Vertex將以100億美元收購Crinetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679469","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679469?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:08","pubTimestamp":1783368527,"startTime":"0","endTime":"0","summary":"Vertex将以100亿美元收购Crinetics路透7月6日-Vertex Pharmaceuticals（VRTX.O）将以约100亿美元的总股权价值收购Crinetics Pharmaceuticals（CRNX.O），两家公司周一宣布了这一消息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4S4381BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","LU1069344957.HKD","LU2462157665.USD","SG9999013999.USD","LU0889565916.HKD","LU2362540622.SGD","IE00BJT1NW94.SGD","BIB","LU1035775433.USD","LU2324357040.USD","BK4532","IDNA","BK4588","IBBQ","LU2456880835.USD","BBH","PBE","LU0109394709.USD","LU0058720904.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0823416689.USD","VRTX","LU0417517546.SGD","IE00BZ9MQY76.HKD","LU0432979614.USD","LU2417539215.USD","CRNX","LU0320765992.SGD","LU1585245621.USD","LU0079474960.USD","IE00B19Z3B42.SGD","LU0061475181.USD","IE00B19Z3581.USD","LU1093756325.SGD","LU2237438978.USD","BK4585","IE00B2B36J28.USD","IE0002270589.USD","LU1674673428.USD","BK4139","LU1778281490.HKD","IBB","LU1674673691.USD","BK4567","IE00B894F039.SGD","IE00B19Z9P08.USD","LU0256863811.USD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833937","title":"Crinetics與福泰製藥交易預計2029年提升後者非GAAP運營收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127833937?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:07","pubTimestamp":1783368452,"startTime":"0","endTime":"0","summary":"根据最新披露的财务预测，Crinetics Pharmaceuticals Inc. 与福泰制药达成的战略合作，预计将在2029年对福泰制药的非通用会计准则运营收入产生积极贡献。\n此次交易的结构设计旨在通过长期协同效应，增强福泰制药的盈利质量。分析指出，该合作不仅将拓展福泰制药在特定治疗领域的产品管线，还可能优化其整体运营效率。市场预期，随着合作项目进入成熟阶段，其对财务指标的正面影响将逐步显现。\n财务模型显示，此次合作带来的收入增长与成本协同效应，是推动非通用会计准则运营收入提升的关键因素。投资者正密切关注交易细节及后续整合进程，以评估其长期价值创造潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU0432979614.USD","CRNX","IE00B894F039.SGD","IDNA","IE00BJJMRZ35.SGD","LU0417517546.SGD","LU1674673691.USD","IE00B19Z3581.USD","LU2362541273.HKD","LU2237438978.USD","IE0002270589.USD","LU1585245621.USD","IE00BZ9MQY76.HKD","SGXZ57979304.SGD","LU2462157665.USD","SG9999001176.USD","BK4007","LU1093756168.USD","LU2362540622.SGD","BIB","LU1093756325.SGD","IE00B19Z9P08.USD","LU1035775433.USD","LU2456880835.USD","LU0823416689.USD","LU2236285917.USD","IE00B4R5TH58.HKD","LU2324357040.USD","BK4585","LU1674673428.USD","SG9999013999.USD","BK4532","LU2417539215.USD","LU1430594728.SGD","LU0061475181.USD","BK4533","LU0889565916.HKD","IE00B2B36J28.USD","LU0109394709.USD","IE0009355771.USD","IE00B19Z3B42.SGD","LU2362541513.USD","IE0002141913.USD","LU0256863811.USD","LU1778281490.HKD","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","VRTX","BBH","IBB","LU1069344957.HKD","BK4567","SG9999001176.SGD","LU0234570918.USD","LU0058720904.USD","IE00BJT1NW94.SGD","PBE","BK4588","BK4139","LU0079474960.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179291339","title":"Crinetics Pharmaceuticals：融資獲美國銀行與摩根士丹利的45億美元全額承諾過橋貸款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179291339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179291339?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:06","pubTimestamp":1783368378,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 的融资计划，已获得来自美国银行和摩根士丹利高级融资部门提供的总额高达45亿美元的全额承诺过桥贷款支持。这笔资金将为公司的战略推进提供坚实的财务后盾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BBH","IBB","LU1069344957.HKD","LU2462157665.USD","IE00B19Z3581.USD","SG9999001176.USD","BK4567","LU0256863811.USD","BK4533","BIB","LU1035775433.USD","LU1585245621.USD","IE0009355771.USD","PBE","LU2362540622.SGD","LU1093756168.USD","LU1778281490.HKD","IE0002270589.USD","LU2236285917.USD","LU0889565916.HKD","LU0432979614.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU1093756325.SGD","LU2456880835.USD","LU2362541513.USD","SGXZ57979304.SGD","LU1430594728.SGD","IE00BJJMRZ35.SGD","IE00B19Z9Z06.USD","LU0058720904.USD","BK4588","CRNX","LU0823416689.USD","LU2324357040.USD","LU2417539215.USD","SG9999013999.USD","BK4139","IE00BZ9MQY76.HKD","LU0079474960.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE00B894F039.SGD","SG9999001176.SGD","LU0289739699.SGD","BK4007","IBBQ","IE00B19Z3B42.SGD","LU0417517546.SGD","LU1674673428.USD","VRTX","BK4532","IDNA","IE00B19Z9P08.USD","LU0061475181.USD","LU0234570918.USD","LU2237438978.USD","IE0002141913.USD","IE00B2B36J28.USD","LU1674673691.USD","BK4585","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154393441","title":"福泰製藥就囊性纖維化療法Alyftrek與泛加拿大藥品聯盟簽署意向書","url":"https://stock-news.laohu8.com/highlight/detail?id=1154393441","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154393441?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 22:25","pubTimestamp":1783347947,"startTime":"0","endTime":"0","summary":"福泰制药与泛加拿大药品联盟就囊性纤维化治疗药物Alyftrek的潜在合作签署了意向书。此举标志着该药物在加拿大市场准入进程中的一个重要步骤，旨在为患者提供新的治疗选择。意向书的签署为后续正式协议的谈判奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","IE00B4R5TH58.HKD","LU1069344957.HKD","LU2462157665.USD","SG9999013999.USD","LU0889565916.HKD","LU2362540622.SGD","LU1093756168.USD","IE00BJT1NW94.SGD","LU1430594728.SGD","BIB","IE00B19Z9Z06.USD","LU1035775433.USD","BK4532","IDNA","LU2324357040.USD","SGXZ57979304.SGD","BK4588","LU2362541273.HKD","IBBQ","LU2456880835.USD","LU0234570918.USD","BBH","PBE","LU0109394709.USD","LU0058720904.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0823416689.USD","IE00BJJMRZ35.SGD","BK4533","LU0417517546.SGD","VRTX","IE00BZ9MQY76.HKD","LU0432979614.USD","LU2417539215.USD","SG9999001176.USD","LU0320765992.SGD","LU1585245621.USD","LU0079474960.USD","IE00B19Z3B42.SGD","LU0061475181.USD","IE00B19Z3581.USD","LU1093756325.SGD","LU2237438978.USD","BK4585","IE00B2B36J28.USD","IE0002270589.USD","LU1674673428.USD","BK4139","LU1778281490.HKD","IBB","LU1674673691.USD","BK4567","IE0009355771.USD","LU2362541513.USD","IE00B894F039.SGD","IE00B19Z9P08.USD","LU0256863811.USD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132494711","title":"再生元製藥公司預計2026年第二季度GAAP及非GAAP每股攤薄收益將減少1美元——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1132494711","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132494711?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 19:03","pubTimestamp":1783335796,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，再生元制药公司（Regeneron Pharmaceuticals）预计，其2026年第二季度的美国通用会计准则（GAAP）及非美国通用会计准则（Non-GAAP）每股摊薄收益将出现下降，减少幅度约为1美元。这一预期反映了公司在特定时期内的财务表现可能面临的调整或挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434583.USD","LU0889565916.HKD","LU2089984988.USD","LU0320765992.SGD","LU0289739699.SGD","LU0109394709.USD","LU2106854487.HKD","IBB","LU0053666078.USD","IBBQ","LU2237438978.USD","LU0114720955.EUR","LU2362541513.USD","LU1917777945.USD","BBH","LU2362541273.HKD","BK4139","LU2362540622.SGD","LU0823416689.USD","LU0823434740.USD","LU2468319806.SGD","BK4588","LU1974910355.USD","LU0058720904.USD","LU2023250504.SGD","LU0882574055.USD","REGN","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649462386","title":"景澤生物三次遞表港交所，核心產品均為生物類似藥，投後估值約32.1億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649462386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649462386?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 18:12","pubTimestamp":1783332779,"startTime":"0","endTime":"0","summary":"一款核心产品已获批上市一年多，尚未产生收入","market":"hk","thumbnail":"https://img2.gelonghui.com/6475f-76e0e400-d516-42c4-bd42-eb561753a368.jpg?guru_height=906&guru_width=1362&guru_size=182799","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/6475f-76e0e400-d516-42c4-bd42-eb561753a368.jpg?guru_height=906&guru_width=1362&guru_size=182799"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5471876","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU1992135472.HKD","IE00B5TLWC47.USD","IPOS","LU2272731865.HKD","LU2322448791.USD","IBB","XPH","BK4585","HEXmain","LU2272731600.USD","LU2272731782.SGD","LU2322448957.HKD","BK4588","LU1992135399.USD","PPH","LU2473716301.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649644013","title":"美國研究綜述-東西銀行、第一公民銀行控股公司、UMB","url":"https://stock-news.laohu8.com/highlight/detail?id=2649644013","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649644013?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 16:22","pubTimestamp":1783326173,"startTime":"0","endTime":"0","summary":"美国研究综述-东西银行、第一公民银行控股公司、UMB路透7月6日-周一，华尔街证券分析师下调了多家在美国上市公司的评级和目标股价，其中包括东西银行、第一公民银行控股公司和UMB金融公司。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4S4380GO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEMG","UNH","OZK","GILD","RGLD","CVS","DLTR","FCNCA","SOC","BBH","PAWZ","REGN","CFR","EWBC","USB","JNJ","UMBF","UNHG","IBB","IHE","ABBV","DFNL","PNFP","UNHW","PBLS","FRBT","PFE","NEM","HBAN","MEDI","IQV","CBSH","AGMI","BIIB","QABA","FLG","PJP","XLV","ZION","OZEM","WTFC","IHF","MRK","EKG","FTXH","AGNG","ADP","ZTS","EROC","CCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142675479","title":"禮來與再生元製藥公司入選FDA首批加速新生產設施審查計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1142675479","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142675479?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 15:15","pubTimestamp":1783322114,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）近日启动了一项旨在加速新生产设施审查的倡议，而制药巨头礼来与再生元制药公司成为首批入选该计划的企业。此举旨在通过优化监管流程，缩短创新药物生产设施从建设到获批投产的时间，从而更快地将关键疗法推向市场。\n对于礼来和再生元而言，参与此计划意味着其未来新建或扩建的生产基地可能获得FDA更优先、更高效的审查。在当前全球生物制药竞争日益激烈的背景下，提升产能布局的敏捷性至关重要，尤其是在糖尿病、肥胖症、癌症及炎症性疾病等需求旺盛的治疗领域。这一监管合作模式有望成为行业加速发展的新催化剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014906.USD","LU0889565916.HKD","LU2417539215.USD","XLV","FHLC","LU1814569148.SGD","LU2552382132.HKD","LU0316494557.USD","PJP","LU2265009873.SGD","LU0198837287.USD","LU2471134952.CNY","LU0158827948.USD","LU0203202063.USD","LU2168563687.JPY","IBB","IE00BK4W5M84.HKD","LLYZ","LU2023250330.USD","LU2168564065.EUR","SG9999018865.SGD","BK4534","LU1366192091.USD","IE0004445239.USD","LU0471298694.HKD","LU0882574139.USD","LU0353189763.USD","LU0079474960.USD","LU2211815571.USD","LU2552382058.USD","LU0823416689.USD","IE0004445015.USD","LU1291159041.SGD","LU2468319806.SGD","LU2108987350.USD","LU1551013342.USD","LU2361045086.USD","LU2168564222.USD","LU0354030511.USD","LU0234572021.USD","IE00B775H168.HKD","LU2750360997.AUD","LU2461242641.AUD","IE00BJJMRY28.SGD","LU0058720904.USD","LU0943347566.SGD","LU2264538146.SGD","LU2756315318.SGD","JDOC","IE00B2B36J28.USD","LU1988902786.USD","LU1868837136.USD","LU0266013472.USD","IE00B1XK9C88.USD","LU2089984988.USD","LU2112291526.USD","MEDI","LU0203201768.USD","LU2491050071.SGD","LU2106854487.HKD","LU2360106947.USD","LU2552382215.SGD","LU1720051108.HKD","LU0672654240.SGD","OZEM","SG9999014914.USD","LU2602419157.SGD","LU2471134796.USD","REGN","LU0964807845.USD","LU1551013425.SGD","LU0225283273.USD","LU0323591593.USD","LU0053666078.USD","LU0456855351.SGD","LU0471298777.SGD","LU1629891620.HKD","LU2362541513.USD","LU0256863811.USD","BBH","IE00BJJMRX11.SGD","LU1232071149.USD","LU0345770308.USD","LU0122379950.USD","LU0689472784.USD","LU2746668974.SGD","LU2362540622.SGD","SG9999014898.SGD","SG9999015945.SGD","GB00BDT5M118.USD","LU2237443382.USD","LU1804176565.USD","LU0094547139.USD","IE00BFTCPJ56.SGD","WDNA","IHE","RXL","LU1069344957.HKD","SG9999015986.USD","IE00BKDWB100.SGD","IE0009355771.USD","LU1983299246.USD","BK4588","LLYX","LU1974910355.USD","LU2237443978.SGD","LU1548497426.USD","SG9999015952.SGD","LU2063271972.USD","LU0882574055.USD","IE00BWXC8680.SGD","LU2750360641.GBP","IE0002141913.USD","IE00B7KXQ091.USD","LU2756315664.SGD","LU1061106388.HKD","LU0823434583.USD","LU0353189680.USD","LU2023251221.USD","MEDX","CURE","IE0001KFT4U8.USD","LU0256863902.USD","LU0289739699.SGD","LU2237443549.SGD","LU2471134523.USD","LU2361044865.SGD","SG9999001176.USD","LU2168564495.EUR","LU0786609619.USD","LU0238689110.USD","LU2236285917.USD","LU0787776722.HKD","LU1023059063.AUD","LU2746668461.USD","LU0096364046.USD","LU2462157665.USD","IE00BJLML261.HKD","BK4581","LU0320765059.SGD","LLII","LU0106261372.USD","ELIS","IBBQ","IE00B4R5TH58.HKD","LU0114720955.EUR","SGXZ81514606.USD","LU0385154629.USD","LU2471134879.HKD","BK4139","LU0061475181.USD","LU2237443622.USD","SG9999013999.USD","LU0109391861.USD","LU1868836757.USD","LU1093756325.SGD","LU0466842654.USD","PPH","LU1267930730.SGD","LU1712237335.SGD","LU0683600562.USD","IE00B4JS1V06.HKD","THNR","LU1057294990.SGD","IE00B1BXHZ80.USD","LU2271345857.HKD","LU0097036916.USD","LU0820561818.USD","LU1868836914.USD","LU2896262040.SGD","IXJ","LU2237443895.HKD","BK4533","IE00BK4W5L77.USD","IE00BN29S564.USD","HRTS","SG9999001176.SGD","LU0432979614.USD","LU0133085943.USD","IE0005OL40V9.USD","SGXZ99366536.SGD","LU0640476718.USD","LU0354030438.USD","LU0158827781.USD","LU2491049909.HKD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0109394709.USD","SGXZ57979304.SGD","LU2324357040.USD","LU2237443465.HKD","LU1145028129.USD","LU2087625088.SGD","ILDR","LU2361044949.HKD","LU1868836591.USD","LU1093756168.USD","LU1127390331.HKD","LU2028103732.USD","LU1280957306.USD","LU2491050154.USD","IYH","LU2237438978.USD","SG9999018857.SGD","LU1917777945.USD","SG9999017495.SGD","LU2362541273.HKD","VHT","IE00BFSS8Q28.SGD","BK4516","IE00BKPKM429.USD","LU0210536198.USD","LU0417517546.SGD","SG9999015978.USD","LU2456880835.USD","LU2111349929.HKD","LU0820562030.AUD","AGNG","LU0823434740.USD","CANC","LU2089283258.USD","LU0345770993.USD","LU1035775433.USD","LU2168564149.EUR","LU2089284900.SGD","IE00BFSS7M15.SGD","BK4007","SGXZ31699556.SGD","LU2357305700.SGD","LU0708995401.HKD","SG9999014880.SGD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU0820561909.HKD","LU1064131342.USD","LU2023250504.SGD","LU2213496289.HKD","LU1868837300.USD","LU1623119135.USD","SGXZ51526630.SGD","GDOC","LU1720051017.SGD","BK4599","LLY","ELIL","LU1989771016.USD","LU0006306889.USD","FTXH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649646268","title":"《股市簡訊》香港華夏恒生生科ETF漲5.7%創近兩個月新高，管理人料低估修復","url":"https://stock-news.laohu8.com/highlight/detail?id=2649646268","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649646268?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 14:51","pubTimestamp":1783320665,"startTime":"0","endTime":"0","summary":"《股市简讯》香港华夏恒生生科ETF涨5.7%创近两个月新高，管理人料低估修复* 追踪恒生生物科技指数.HSBIO的华夏恒生生科3069.HK周一盘中一度涨5.7%至14.78港元，创近两个月新高。他并称，美国同类型ETF-道富健康照护精选产业XLV.P、安硕生物科技IBB.O已创出历史新高，因此判断中国生物科技产业会出现低估修复。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4T4380D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XLV","XBI","LABU","IBB","BK4585","03069","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112712189","title":"ETF日報｜2倍沽空閃迪ETF 漲逾28%；三倍沽空半導體ETF 漲近17%；成長承壓、貴金屬走強","url":"https://stock-news.laohu8.com/highlight/detail?id=1112712189","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112712189?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 08:42","pubTimestamp":1783039362,"startTime":"0","endTime":"0","summary":"2倍做多AVAV ETF-Defiance上涨21.55%。美股ETF跌幅Top5Corgi ACLS 2x Daily ETF下跌37.68%。大盘指数ETF涨幅Top 5纳指三倍做空ETF上涨5.46%。大宗商品ETF涨幅Top 5二倍做多黄金矿业指数ETF-Direxion上涨8.61%。2倍做多黄金ETF-ProShares上涨4.08%。行业指数ETF涨幅Top 5三倍做空半导体ETF-Direxion Daily上涨16.84%。该产品三倍做空半导体板块，板块回落令反向产品大幅走高。债券ETF涨幅Top 5Infracap REIT Preferred ETF上涨1.20%。总结当日ETF结构显示科技成长承压，半导体多头显著回撤，做空半导体与做空纳斯达克100指数产品领涨。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e2482c489456454bb2227ec34bbeb7d8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDXJ","ACLZ","QID","AGQ","AVXX","EWG","UYM","UCTX","EMLC","EWU","SQQQ","PFFR","ACMM","DRN","IREZ","EBND","VRP","AEHG","LEMB","UDOW","NUGT","UGL","FOMG","IBB","SNDQ","MRNX","APPC","SOXS","GDX","FAS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1153818821","title":"ETF日報｜2倍做多Firefly Aerospace ETF升逾36%；2倍做多Arm ETF升逾32%；成長科技與貴金屬雙強","url":"https://stock-news.laohu8.com/highlight/detail?id=1153818821","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153818821?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 10:25","pubTimestamp":1774491900,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5$2倍做多SRPT ETF-Tradr$上涨69.23%。Sarepta Therapeutics周三大涨近35%，此前该公司公布了两项治疗罕见肌肉萎缩症的初步数据。该产品两倍做多航空航天公司$Firefly Aerospace$，标的股价上行带动产品大幅走高，杠杆效应放大收益。有报道称埃隆马斯克旗下的SpaceX最快将于本周提交上市申请，周三太空概念股应声飙升，Firefly Aerospace涨超16%，Intuitive Machines涨近15%，Planet Labs涨超11%，Rocket Lab和AST SpaceMobile涨超10%。$2倍做多ARM ETF- Leverage Shares$上涨32.51%。$罗素2000指数三倍做多ETF-Direxion$上涨3.63%。债券ETF涨幅Top 5$Infracap REIT Preferred ETF$上涨1.33%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFFR","SPTL","PLU","ARM","CHAU","PL","DKNX","LUNR","AGQ","IBB","NLR","PCY","FLY","ARMG","ASTS","EDC","UYM","ASTN","SOXL","NUGT","YINN","TNA","EMB","SLV","DKNG","SMCI","LUNL","XPP","AMD","FLYT","RKLZ","SRPU","UGL","TLT","DGP","SRPT","SMCZ","RKLB","TAN","DAMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177597123","title":"ETF日報｜2倍做多Hims & Hers ETF升逾81%；三倍做多半導體ETF升逾11%；成長風格領跑","url":"https://stock-news.laohu8.com/highlight/detail?id=1177597123","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177597123?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 10:30","pubTimestamp":1773109800,"startTime":"0","endTime":"0","summary":"大宗商品中，白银相关ETF显著走强，原油做多品种回落。该产品两倍做多在线医疗平台公司$Hims & Hers Health$，因底层公司股价上涨，杠杆机制放大当日涨幅。$诺和诺德$计划在Hims & Hers Health平台销售减重药物，双方结束此前的法律纠纷，公司股价大幅上涨。该产品围绕Hims & Hers Health开展期权收益策略，因公司股价上行，份额净值同步走高。$2倍做多恐慌指数期货ETF$下跌19.40%。行业指数ETF涨幅Top 5$三倍做多半导体ETF-Direxion Daily$上涨11.34%。债券ETF涨幅Top 5$First Trust SSI Strategic Convertible Securities ETF$上涨2.02%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMNR","CWB","RDW","LU2249611893.SGD","UVIX","BK4585","SLV","RCAX","BEG","CRCD","RDWU","LU2543165471.USD","SOXL","TUR","BEZ","HIMZ","LU0823414478.USD","LU1988902786.USD","XLK","LU2357125470.USD","LU1815336760.USD","NUGT","FCVT","LU2294711713.HKD","HIMS","SPLB","DGZ","LITE","LU0476273544.USD","BK4550","OIH","BMNZ","LU1642822529.SGD","BK4588","LU0823414551.USD","NLR","SMH","EDC","AGQ","BK4182","LU2506951792.HKD","IBB","VCLT","BK4541","LU1064131342.USD","TQQQ","ICVT","EWY","LU0957808578.USD","HIYY","LITX","YINN","LU2264538146.SGD","LU0444973449.USD","LU0444971666.USD","BE","CRCL"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":54,"code":"91000000","status":"200"}]}}